Simvastatin-Induced Lupus-Like Syndrome
Document Type
Article
Publication Date
1-1-2000
Description
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are widely used as cholesterol lowering agents that have an acceptable safety profile. As a group, this class of drugs has been associated with few immunologic reactions. Simvastatin (Zocor) has been linked to three cases of drug-induced lupus-like syndrome. We report the case of an additional patient who developed pleurisy and arthralgia after he started taking this low-density lipoprotein and cholesterol-lowering agent.
Citation Information
Ahmad, A.; Fletcher, M. T.; and Roy, T. M.. 2000. Simvastatin-Induced Lupus-Like Syndrome. Tennessee medicine : journal of the Tennessee Medical Association. Vol.93(1). 21-22. https://pubmed.ncbi.nlm.nih.gov/10628262/ PMID: 10628262 ISSN: 1088-6222